about
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF ...
Read More
2.11
0.03
(1.44%)
1.6M
XNAS Volume
XNAS 29 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Erasca Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..